x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Dr. Chapa"s OBGYN No Spin Podcast

Relevant, evidence based, and practical information for medical students, residents, and practicing healthcare providers regarding all things women’s healthcare! This podcast is intended to be clinically relevant, engaging, and FUN, because medical education should NOT be boring! PLUS...we believe that medical education should be delivered without any SPIN...Welcome, to Dr. Chapa"s OBGYN No Spin Podcast! (Note: our Legacy podcast, Clinical Pearls, will no longer have new episodes uploaded through

education medicine

All Episodes

24:48

IUD, Cytology, and Actinomyces: Management.

Dr. Chapa"s OBGYN No Spin Podcast ·

2025/11/30

Actinomyces species are considered part of the normal vaginal and urogenital tract flora. The percentage of Pap smears containing Actinomyces-like organisms varies but is most commonly reported as approximately 7% among women using IUDs. That number is supported by multiple sources, including the Infectious Diseases Society of America guideline and several clinical studies. The incidence can be higher or lower depending on the type of IUD; for example, copper IUDs have been associated with rates up

en

17:13

LDA for Unexplained Recurrent SABs?

Dr. Chapa"s OBGYN No Spin Podcast ·

2025/11/26

Recurrent pregnancy loss (RPL) affects approximately 5% of couples and is an emotional burden on those affected. There is some evidence that vaginal progesterone supplementation may be considered in patients with recurrent pregnancy loss who are experiencing vaginal bleeding during the first trimester. But what about prophylactic low dose aspirin in the first trimester, or preconceptionally, for unexplained RPL? Is that evidence-based? A new publication from the SMFM’s journal Pregnancy has examined

en

27:48

Change Gloves After Placenta at CS? Yes, and No.

Dr. Chapa"s OBGYN No Spin Podcast ·

2025/11/24

Having data is sometimes different than having clinically applicable data. This is exactly the issue with the proposed plan to reduce surgical site infection (SSI) by changing surgical gloves after placental delivery at C-Section. Just 24 hours ago, we received the question from a PGY4 OBGYN resident asking whether the practice of changing surgical gloves at C-Section after placental delivery to reduce SSI was evidence-based. So, in this episode, we will review the data - which is timely since this

en

24:45

Refresher of Genetic MD

Dr. Chapa"s OBGYN No Spin Podcast ·

2025/11/21

Muscular dystrophy (MD) is a group of genetic diseases that affect about 16 to 25 per 100,000 people in the US, with the most common childhood form being Duchenne muscular dystrophy (DMD) and the most common adult form being myotonic dystrophy. The prevalence of DMD is estimated at around 1 in 3,500 live male births. Prenatal carrier screening for this is part of the ACMG Tier 3 expanded carrier panel. This is different from spinal muscular atrophy (SMA). As we recently had a patient who was a MD

en

35:42

Use GA at CS Electively? Maybe, Maybe.

Dr. Chapa"s OBGYN No Spin Podcast ·

2025/11/19

Regional anesthesia, typically with a spinal or epidural, has long been favored for cesarean births due in part to concerns about the effects that general anesthesia (GA) may have on newborns at delivery. However, data has shown that up to 1 in 6 women may experience pain with a “topped-off” labor epidural, during the cesarean. A new publication in the journal Anesthesia is now being interpreted as implying that general anesthesia may be a valid alternative electively. Is that what this new study

en

19:38

Lido Patches After CS? Maybe.

Dr. Chapa"s OBGYN No Spin Podcast ·

2025/11/18

The US has no shortage of lidocaine patch television commercials. Topical lidocaine has a role for local, topical, minor aches and pains. What about lidocaine patches for post-op cesarean section pain? Is there data for that? A brand-new meta-analysis in AJOG-MFM (Nov 13, 2025) looks at this option. However, there has been 3 prior reviews on the same topic from 2019, 2022, and 2023. Do they all arrive at the same result? Listen in for details!1. Smoker J, Cohen A, Rasouli MR, Schwenk ES. Transdermal

en

30:46

More Measles Material

Dr. Chapa"s OBGYN No Spin Podcast ·

2025/11/17

Podcast Family, we have covered the subject of Measles previously on this show (links below). Those episodes were a preview of what has now been released ahead of print as a narrative review in the Green Journal! In this episode, we will summarize the KEY points of measles infection in pregnancy and re-state the “rule of 4” and the importance of the number 10 regarding this.1. Feb 24, 2025: Measles 101: https://open.spotify.com/episode/4lXrpqKTJPdDcTXPxpEmcb2. April 27, 2019: Measles!! ACOG Practice

en

17:44

Self-Hypnosis For Hot Flash Relief.

Dr. Chapa"s OBGYN No Spin Podcast ·

2025/11/12

The term "hypnosis" was first described in 1843 by Scottish surgeon James Braid, who published the book Neurypnology. He coined the term "hypnosis" from the Greek word for sleep to describe the trance-like state induced by focusing on a bright object. Self-hypnosis has now been shown to aid in menopausal hot flash reduction! In this episode, we will review this brand new publication from JAMA Network which confirmed via a multicenter RCT that a simple daily hypnosis audio session was effective for

en

31:46

That’s So Random!

Dr. Chapa"s OBGYN No Spin Podcast ·

2025/11/12

Well, from time to time we cover RANDOM tidbits of information which cover RANDOM questions and/or RANDOM patient care issues that we encounter. In this episode we will cover one OB issue related to recurrent pregnancy loss, one GYN issue related to unilateral breast swelling in a patient with SLE, and one RANDOM life perspective response from a mock interview that I participated in for a residency candidate. Listen in for details!1. Factor V and recurrent pregnancy loss: de Assis, Viviana DO;

en

14:48

HISTORY MADE: New HRT News TODAY (11/10/25)

Dr. Chapa"s OBGYN No Spin Podcast ·

2025/11/10

On August 15, 2025, we reviewed the data from an FDA expert panel calling on the FDA to remove the exiting Black Box warning on commercial HRT options for menopausal care. In a historic decision, this happened today. Listen in for details! 1. https://www.cbsnews.com/video/fda-chief-explains-changes-to-black-box-warnings-on-some-hormone-therapies-for-menopause/2. https://www.hhs.gov/press-room/hhs-advances-womens-health-removes-misleading-fda-warnings-hormone-replacement-therapy.html

en

24:14

A BMI-Based Labor Curve?

Dr. Chapa"s OBGYN No Spin Podcast ·

2025/11/09

The ACOG acknowledges that maternal obesity affects labor curves and recommends allowing more time for cervical dilation before diagnosing labor arrest in obese patients. This approach aims to avoid unnecessary interventions, such as premature cesarean delivery, which may occur if standard labor curves are strictly applied to obese women. In this episode, we will review a new study from the AJOG (08 Nov 2025) which describes labor progression and duration according to maternal body mass index,

en

28:22

Use Antibiotics at 2nd Degree OB Lac Repair?

Dr. Chapa"s OBGYN No Spin Podcast ·

2025/11/06

Do you routinely order prophylactic antibiotics at time of second-degree laceration repair? Is there data for that? While the use of prophylactic antibiotics “is reasonable” (per ACOG PB 198) for OASIS lacerations, what does the data look like for second degree lacs? Well, the answer is both supportive AND non-supportive of that practice! In this episode, we will cover a brand new publication (RCT) from BMJ on this very issue, and also highlight a meta-analysis from Plos One (May 2025) that also

en

30:38

“New” PCOS Info: 4 Types (AGAIN)

Dr. Chapa"s OBGYN No Spin Podcast ·

2025/11/05

On March 29, 2023, we released an episode titled, “The 4 PCOS Phenotypes”. That was in 2023! Now, on 29 October 2025, in the journal Nature Medicine, researchers have published, “Data-driven (FOUR) subtypes of polycystic ovary syndrome and their association with clinical outcomes”. PCOS is not ONE condition: is a constellation of metabolic, endocrine, and ovulatory dysregulation. We covered these 4 phenotypes back then. Is this what the “new data” found? Or what it something else? And how does these

en

29:02

Folic Acid Update: Patients on Epilepsy Meds Do NOT...

Dr. Chapa"s OBGYN No Spin Podcast ·

2025/11/02

Taking folic acid prior to conception and during pregnancy can help protect the unborn baby from developing abnormalities. Supplements are particularly important for women who have epilepsy, as anti-seizure medication (previously known as anti-convulsants or anti-epileptic drugs) can lead to a deficiency in folic acid. Until 2023, high doses of 4-5 mg per day were recommended. However, this has changed as the data has changed. Did you know the SMFM no longer recommends “high dose” folic acid

en

21:24

Whole Blood for PPH!

Dr. Chapa"s OBGYN No Spin Podcast ·

2025/10/31

Back on August 9, 2024, we released an episode (link in the show notes) reviewing the renewed interest in transfusing whole blood for PPH rather than component therapy. Now, in O&G open, authors from my Alma Mater (UT Southwestern) have published new data bolstering the use of whole blood for PPH. Listen in for details.1. https://open.spotify.com/episode/0ZhqoIE9wMcAboDlevq9OW?si=rM32uK8ER8uuWmq4mf5dzA2. Ambia, Anne M. MD; Burns, R. Nicholas MD; White, Alesha MD; Warncke, Kristen MD; Gorman,

en

21:57

New Med For Hot Flashes

Dr. Chapa"s OBGYN No Spin Podcast ·

2025/10/30

Elinzanetant, sold under the brand name Lynkuet, received approval from the U.S. Food and Drug Administration (FDA) on October 24, 2025, for the treatment of moderate to severe hot flashes due to menopause. How is this different than Fezolinetant, which was approved in 2023? Listen in for details. 1. Menegaz de Almeida, Artur MS; Oliveira, Paloma MS; Lopes, Lucca MD; Leite, Marianna MS; Morbach, Victória MS; Alves Kelly, Francinny MD; Barros, Ítalo MS; Aquino de Moraes, Francisco Cezar MS;

en

21:28

Vaginal Vit C For BV? AGAIN!

Dr. Chapa"s OBGYN No Spin Podcast ·

2025/10/27

On January 18, 2020, we released an episode called “Vaginal Vit C for BV? Yep, it’s DATA”. That was 5 years ago! Now, in the Green Journal, a new systematic review and meta-analysis is examining this subject….AGAIN. Plus, this is not the only systematic review to investigate this; a similar review was published in Acta Obstétrica e Ginecológica Portuguesa earlier this year (2025) in March. So, did we get it right 5 years ago? Can vaginal Vit C help in eliminating BV? Listen in for details!1.

en

30:28

AFLP vs Preeclampsia With Severe Features/HELLP

Dr. Chapa"s OBGYN No Spin Podcast ·

2025/10/24

Here is a real-world clinical case with a tricky differential: Our team recently readmitted a patient 6 days postpartum/post C-section (which was done for ICP and fetal macrosomia at close to 4500 grams, with A2GDM). She had elevated blood pressures, a frontal headache, some midepigastric pain/RUQ discomfort. Pretty clear picture right: sounds like preeclampsia (PreE) with severe features based on BP elevation and symptoms. So, we started her on mag-sulfate per protocol. Well, her transaminases were

en

16:01

Does IV Pitocin Increase Abruption Risk?

Dr. Chapa"s OBGYN No Spin Podcast ·

2025/10/21

I was recently asked to OPINE on the labor management for a patient who was receiving IV Pitocin for augmentation, who experienced a placental abruption. One physician stated that in "his opinion", Pitocin increased the risk of placental abruption intrapartum, a point which the original treating physician refuted. So, I was asked to be the "referee" on the play. IV Pitocin can result in some maternal-fetal complications but is abruption one of them as a stand-alone complication. Was the first

en

29:27

Does Oral PCN Affect OB GBS Culture Result?

Dr. Chapa"s OBGYN No Spin Podcast ·

2025/10/19

Current guidelines recommend universal collection of a vaginal-rectal swab for GBS colonization at 36-37 weeks and 6 days for the identification of patients who require intrapartum IV antibiotic coverage to prevent early onset neonatal GBS infection/sepsis. Recently, we had a patient in clinic whose GBS culture at 36 weeks was negative. Good right? Well, the patient was on amoxicillin at the time for pharyngitis. Did that course of oral PCN based therapy affect the GBS culture result? Should we

en

61 results

Similar Podcasts

Science Talk

Albert Einstein College of Medicine

五分钟心理学

柠檬心理

Daily Facts

Amalia Dupray and Montgomery Jones.

Les dents et dodo

BFMTV

Veterinary Clinical Podcasts

The Royal Veterinary College